Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Shares of Vaxart Are Soaring Today

TheMotleyFool

0 0

Shares of clinical-stage vaccine developer Vaxart (NASDAQ: VXRT) are up again today, gaining 12.34% to $9.83 apiece as of 2:30 p.m. EDT. The stock is up 21% over the past five trading days due to greater capital inflows after the company released encouraging second-quarter earnings on Aug. 5.

Vaxart managed to raise $36.2 million during the quarter via issuing new stock -- bringing its cash balance to $177.3 million. That is quite significant for a company with a market cap just north of $1 billion. In addition, the company received clearance from the U.S. Food and Drug Administration to move into phase 2 clinical trials for its experimental oral coronavirus vaccine.

Image source: Getty Images.

Source Fool.com

Like: 0

VXRT

Share